Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

Treanor, John J ; Kotloff, Karen ; Betts, Robert F ; Belshe, Robert ; Newman, Fran ; Iacuzio, Dominick ; Wittes, Janet ; Bryant, Martin

Vaccine, 1999-12, Vol.18 (9), p.899-906 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques

Hirao, Lauren A ; Wu, Ling ; Khan, Amir S ; Hokey, David A ; Yan, Jian ; Dai, Anlan ; Betts, Michael R ; Draghia-Akli, Ruxandra ; Weiner, David B

Vaccine, 2008-06, Vol.26 (25), p.3112-3120 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive

Hutnick, Natalie A ; Carnathan, Diane ; Demers, Korey ; Makedonas, George ; Ertl, Hildegund C.J ; Betts, Michael R

Vaccine, 2010-02, Vol.28 (8), p.1932-1941 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy

Caley, Ian J ; Betts, Michael R ; Davis, Nancy L ; Swanstrom, Ronald ; Frelinger, Jeffrey A ; Johnston, Robert E

Vaccine, 1999-08, Vol.17 (23), p.3124-3135 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Approaches to improved influenza vaccination

Betts, Robert F. ; Treanor, John J.

Vaccine, 2000-02, Vol.18 (16), p.1690-1695 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects

Treanor, John J. ; Betts, Robert F.

Vaccine, 1998-11, Vol.16 (18), p.1756-1760 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects: Vaccines '97/IASIA

TREANOR, J. J ; BETTS, R. F

Vaccine, 1998, Vol.16 (18), p.1756-1760 [Periódico revisado por pares]

Oxford: Elsevier

Texto completo disponível

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A

Stylianou, E ; Griffiths, K.L ; Poyntz, H.C ; Harrington-Kandt, R ; Dicks, M.D ; Stockdale, L ; Betts, G ; McShane, H

Vaccine, 2015-11, Vol.33 (48), p.6800-6808 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Modeling the durability of ZOSTAVAX® vaccine efficacy in people ≥60 years of age

Li, Xiaoming ; Zhang, Jane H ; Betts, Robert F ; Morrison, Vicki A ; Xu, Ruifeng ; Itzler, Robbin F ; Acosta, Camilo J ; Dasbach, Erik J ; Pellissier, James M ; Johnson, Gary R ; Chan, Ivan S.F

Vaccine, 2015-03, Vol.33 (12), p.1499-1505 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Modeling the durability of ZOSTAVAX registered vaccine efficacy in people greater than or equal to 60 years of age

Li, Xiaoming ; Zhang, Jane H ; Betts, Robert F ; Morrison, Vicki A ; Xu, Ruifeng ; Itzler, Robbin F ; Acosta, Camilo J ; Dasbach, Erik J ; Pellissier, James M ; Johnson, Gary R ; Chan, Ivan SF

Vaccine, 2015-03, Vol.33 (12), p.1499-1505 [Periódico revisado por pares]

Texto completo disponível